PHAT - Phathom Pharmaceuticals Inc Stock Price, Fair Value and News

$7.45-0.37 (-4.73%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

PHAT Price Action

Last 7 days

-5.6%

Last 30 days

-14.7%

Last 90 days

-59.6%

Trailing 12 Months

-17.0%

PHAT RSI Chart

PHAT Valuation

Market Cap

509.4M

Price/Earnings (Trailing)

-1.5

Price/Sales (Trailing)

1.9K

Price/Free Cashflow

-2.06

PHAT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PHAT Fundamentals

PHAT Revenue

Revenue (TTM)

682.0K

Rev. Growth (Qtr)

123.27%

PHAT Earnings

Earnings (TTM)

-339.4M

Earnings Growth (Yr)

-97.9%

Earnings Growth (Qtr)

6.42%

PHAT Profitability

Operating Margin

-534.16%

Return on Equity

181.41%

Return on Assets

-87.7%

Free Cashflow Yield

-48.63%

PHAT Investor Care

Shares Dilution (1Y)

19.43%

Diluted EPS (TTM)

-5.74

PHAT Alerts

2 major insider buys recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	0	0	0	682.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

CEO	Ms. Terrie J. Curran
WEBSITE	phathompharma.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	112

Phathom Pharmaceuticals Inc Frequently Asked Questions

What is the ticker symbol for Phathom Pharmaceuticals Inc? What does PHAT stand for in stocks?

PHAT is the stock ticker symbol of Phathom Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Phathom Pharmaceuticals Inc (PHAT)?

As of Fri Dec 20 2024, market cap of Phathom Pharmaceuticals Inc is 509.41 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PHAT stock?

You can check PHAT's fair value in chart for subscribers.

Is Phathom Pharmaceuticals Inc a good stock to buy?

The fair value guage provides a quick view whether PHAT is over valued or under valued. Whether Phathom Pharmaceuticals Inc is cheap or expensive depends on the assumptions which impact Phathom Pharmaceuticals Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PHAT.

What is Phathom Pharmaceuticals Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, PHAT's PE ratio (Price to Earnings) is -1.5 and Price to Sales (PS) ratio is 1.86 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PHAT PE ratio will change depending on the future growth rate expectations of investors.